External Resources and Dissemination Core

外部资源和传播核心

基本信息

  • 批准号:
    10445254
  • 负责人:
  • 金额:
    $ 20.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Abstract (Research Resources Core) The Research Resources Core (RRC) will support the overarching objective of the CAPRA to accelerate and expand multidisciplinary population-based AD/ADRD research by the development of robust research resources. This core will be dedicated to advancing large population-based research using a variety of rich secondary data sources in order to uncover and shed light on the complex and intertwined social, economic, and health systems effects of AD/ADRD. However, undertaking such analyses requires that researchers understand and surmount specific challenges, including: identifying relevant cohorts of older adults with demonstrated cognitive decline and/or dementia; monitoring short-term and long-term outcomes; and appreciating the local care-delivery environment. Through this core, we will package, create, and facilitate access to databases that help researchers identify relevant cohorts, outcomes of interest, and community factors—to help lower the barriers to their entry to the AD/ADRD research community. Data sources for AD/ADRD research that will be leveraged include Medicare administrative and assessment data, the Health and Retirement Study, the Michigan Long-term Services & Supports Data Archive and relevant publicly available population-based national health surveys. Research-identifiable Medicare and assessment data is both expensive to acquire and requires considerable analyst training; therefore, research with such data are often out-of-reach for researchers. However, simply facilitating access for researchers to Medicare and other large, complex health and healthcare datasets is not sufficient to ensure researchers can conduct rigorous and impactful research, particularly among early stage researchers or those new to AD/ADRD research. In this core, we will lower barriers and make high-quality data functionally accessible to AD/ADRD researchers by providing training products, aggregate data, and algorithms relevant to the field. In doing so, the RRC will also develop and disseminate a series of innovative research training activities, including the Current Topics in Dementia and Alzheimer’s Disease Research podcast & blog (the “CAPRAcast”) and a webinar series devoted to training AD/ADRD researchers (the “CAPRAclass”). We will leverage the expansive, multidisciplinary AD/ADRD research expertise at the University of Michigan and partnered external collaborators to develop resources necessary to support a wide array of AD/ADRD research. The RRC will support and foster multidisciplinary, population-based AD/ADRD research by the development of rigorous AD/ADRD-specific training, the creation and dissemination of research tools, and the provision of access to high-quality data. In this way the core will work synergistically with the other CAPRA cores by providing robust AD/ADRD research resources and training that support the overarching center aims.
项目摘要(研究资源核心) 研究资源核心(RRC)将支持CAPRA的总体目标加速和 通过发展强大的研究扩大基于多学科的AD/ADRD研究 资源。该核心将致力于使用各种富人 次要数据源为了揭示并阐明复杂且交织在一起的社会,经济, 和AD/ADRD的卫生系统效应。但是,进行此类分析需要研究人员 了解和克服特定挑战,包括:确定与 表现出认知能力下降和/或痴呆症;监测短期和长期结果;和 欣赏当地的护理环境。通过这个核心,我们将打包,创建和促进 访问可以帮助研究人员确定相关人群,感兴趣的结果和社区的数据库 因素 - 有助于降低进入广告/ADRD研究社区的障碍。数据源 将要杠杆的广告/ADRD研究包括医疗保险行政和评估数据,健康 和退休研究,密歇根州的长期服务与支持数据档案和相关的公开服务 可用的基于人群的国家卫生调查。研究可识别的医疗保险和评估数据是 既昂贵又需要考虑分析师培训;因此,使用此类数据的研究是 通常对研究人员进行远远。但是,仅支持研究人员访问Medicare和其他 大型,复杂的健康和医疗保健数据集不足以确保研究人员可以进行严格的操作和 有影响力的研究,特别是在早期研究人员或广告/ADRD研究的研究人员中。在这个 核心,通过 提供与该领域相关的培训产品,汇总数据和算法。这样,RRC也会 开发和传播一系列创新的研究培训活动,包括当前的主题 痴呆症和阿尔茨海默氏病研究播客与博客(“ capracast”)和网络研讨会系列专门 培训广告/ADRD研究人员(“ Capraclass”)。我们将利用额外的多学科 密歇根大学的AD/ADRD研究专业知识,并与外部合作者合作开发 支持广泛的广告/ADRD研究所需的资源。 RRC将支持并养育 通过开发严格的广告/ADRD特异性的多学科,基于人群的AD/ADRD研究 培训,研究工具的创建和传播以及提供高质量数据的访问。在 这样,核心将通过提供强大的广告/ADRD研究来与其他Capra核心协同工作 支持总体中心的资源和培训目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew A Davis其他文献

Study of PRD125, a SOAT2-Selective Inhibitor, in Atherogenic Mouse Model.
PRD125(一种 SOAT2 选择性抑制剂)在致动脉粥样硬化小鼠模型中的研究。
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ohshiro T,Sawyer J;Matthew A Davis;Ohtawa M;Nagamitsu T;Lawrence L Rudel;Tomoda H.
  • 通讯作者:
    Tomoda H.

Matthew A Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew A Davis', 18)}}的其他基金

External Resources and Dissemination Core
外部资源和传播核心
  • 批准号:
    10689726
  • 财政年份:
    2020
  • 资助金额:
    $ 20.75万
  • 项目类别:
External Resources and Dissemination Core
外部资源和传播核心
  • 批准号:
    10222558
  • 财政年份:
    2020
  • 资助金额:
    $ 20.75万
  • 项目类别:
THE AVAILABILITY OF CHIROPRACTIC CARE AND USE OF HEALTH SERVICES FOR BACK PAIN
脊椎按摩治疗的可用性和背痛健康服务的使用
  • 批准号:
    9187422
  • 财政年份:
    2015
  • 资助金额:
    $ 20.75万
  • 项目类别:
The United States Complementary and Alternative Medicine Market
美国补充和替代医学市场
  • 批准号:
    8117128
  • 财政年份:
    2010
  • 资助金额:
    $ 20.75万
  • 项目类别:
The United States Complementary and Alternative Medicine Market
美国补充和替代医学市场
  • 批准号:
    7953443
  • 财政年份:
    2010
  • 资助金额:
    $ 20.75万
  • 项目类别:
The United States Complementary and Alternative Medicine Market
美国补充和替代医学市场
  • 批准号:
    8526390
  • 财政年份:
    2010
  • 资助金额:
    $ 20.75万
  • 项目类别:
The United States Complementary and Alternative Medicine Market
美国补充和替代医学市场
  • 批准号:
    8916276
  • 财政年份:
    2010
  • 资助金额:
    $ 20.75万
  • 项目类别:
The United States Complementary and Alternative Medicine Market
美国补充和替代医学市场
  • 批准号:
    8300753
  • 财政年份:
    2010
  • 资助金额:
    $ 20.75万
  • 项目类别:

相似海外基金

Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 20.75万
  • 项目类别:
A software tool to facilitate variable-level equivalency and harmonization in research data: Leveraging the NIH Common Data Elements Repository to link concepts and measures in an open format
促进研究数据中变量级别等效性和协调性的软件工具:利用 NIH 通用数据元素存储库以开放格式链接概念和测量
  • 批准号:
    10821517
  • 财政年份:
    2023
  • 资助金额:
    $ 20.75万
  • 项目类别:
Clinical Decision Support System for Early Detection of Cognitive Decline Using Electronic Health Records and Deep Learning
利用电子健康记录和深度学习早期检测认知衰退的临床决策支持系统
  • 批准号:
    10603902
  • 财政年份:
    2023
  • 资助金额:
    $ 20.75万
  • 项目类别:
Brain Digital Slide Archive: An Open Source Platform for data sharing and analysis of digital neuropathology
Brain Digital Slide Archive:数字神经病理学数据共享和分析的开源平台
  • 批准号:
    10735564
  • 财政年份:
    2023
  • 资助金额:
    $ 20.75万
  • 项目类别:
SCH: Dementia Early Detection for Under-represented Populations via Fair Multimodal Self-Supervised Learning
SCH:通过公平的多模式自我监督学习对代表性不足的人群进行痴呆症早期检测
  • 批准号:
    10816864
  • 财政年份:
    2023
  • 资助金额:
    $ 20.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了